Thomas Condamine

7.8k total citations · 2 hit papers
49 papers, 4.4k citations indexed

About

Thomas Condamine is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Thomas Condamine has authored 49 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 29 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Thomas Condamine's work include Immune cells in cancer (27 papers), CAR-T cell therapy research (21 papers) and Immune Cell Function and Interaction (10 papers). Thomas Condamine is often cited by papers focused on Immune cells in cancer (27 papers), CAR-T cell therapy research (21 papers) and Immune Cell Function and Interaction (10 papers). Thomas Condamine collaborates with scholars based in United States, France and United Kingdom. Thomas Condamine's co-authors include Dmitry I. Gabrilovich, Indu Ramachandran, Judith C. McCaffrey, Pingyan Cheng, Esteban Celis, Je‐In Youn, Jérôme Mastio, Je-In Youn, David Quiceno and Tapan Padhya and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Thomas Condamine

47 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

2010 930 citations Thomas Condamine, Pingyan Cheng et al. profile →
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

2010 691 citations Thomas Condamine, Dmitry I. Gabrilovich Trends in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Condamine United States	21	3.4k	1.7k	1.2k	587	267	49	4.4k
Laura Strauss United States	29	3.2k 0.9×	2.0k 1.2×	1.1k 1.0×	542 0.9×	303 1.1×	46	4.5k
Oakley C. Olson United States	18	2.3k 0.7×	1.5k 0.9×	1.3k 1.2×	702 1.2×	324 1.2×	23	4.2k
Ping‐Ying Pan United States	22	3.1k 0.9×	1.6k 0.9×	698 0.6×	223 0.4×	176 0.7×	39	3.8k
Sergey V. Novitskiy United States	29	1.6k 0.5×	1.6k 1.0×	1.6k 1.4×	665 1.1×	404 1.5×	51	4.0k
Diletta Di Mitri Italy	17	2.2k 0.7×	996 0.6×	724 0.6×	254 0.4×	228 0.9×	24	3.3k
Karin Leandersson Sweden	30	1.7k 0.5×	1.5k 0.9×	1.5k 1.3×	541 0.9×	377 1.4×	69	3.5k
Anna Kiialainen Switzerland	19	1.2k 0.3×	1.0k 0.6×	988 0.9×	335 0.6×	201 0.8×	35	2.9k
Dong‐Ming Kuang China	29	2.7k 0.8×	2.0k 1.2×	943 0.8×	620 1.1×	339 1.3×	48	4.0k
Sophie E. Acton United Kingdom	16	1.8k 0.5×	1.2k 0.7×	623 0.5×	207 0.4×	181 0.7×	26	3.0k

Countries citing papers authored by Thomas Condamine

Since Specialization

Citations

This map shows the geographic impact of Thomas Condamine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Condamine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Condamine more than expected).

Fields of papers citing papers by Thomas Condamine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Condamine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Condamine. The network helps show where Thomas Condamine may publish in the future.

Co-authorship network of co-authors of Thomas Condamine

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Condamine. A scholar is included among the top collaborators of Thomas Condamine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Condamine. Thomas Condamine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdou, Yara, Paula R. Pohlmann, Richard T. Maziarz, et al.. (2024). A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS2682–TPS2682. 4 indexed citations

Beghi, Silvia, Rehman Qureshi, Michael Ball, et al.. (2024). Abstract 5249: Macrophages expressing synthetic cytokine receptors reverse IL10-mediated immunosuppression within solid tumors and promote adaptive immunity. Cancer Research. 84(6_Supplement). 5249–5249. 2 indexed citations

Abdou, Yara, E. Claire Dees, Joanne Mortimer, et al.. (2023). Abstract CT241: A phase 1, first-in-human (FIH) study of autologous anti-HER2 chimeric antigen receptor macrophage (CAR-M) in participants (pt) with HER2 overexpressing solid tumors. Cancer Research. 83(8_Supplement). CT241–CT241. 2 indexed citations

Reiss, Kim A., Joanne Mortimer, Paula R. Pohlmann, et al.. (2023). 635 A phase 1, first in human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2 overexpressing solid tumors. SHILAP Revista de lepidopterología. A726–A726. 1 indexed citations

Gabbasov, Rashid, Alison Worth, Michael Ball, et al.. (2022). 371 Chimeric antigen receptor macrophages (CAR-M) sensitize solid tumors to anti-PD1 immunotherapy. Regular and Young Investigator Award Abstracts. A390–A390. 4 indexed citations

Pierini, Stefano, Rashid Gabbasov, Linara Gabitova, et al.. (2021). Abstract 63: Chimeric antigen receptor macrophages (CAR-M) induce anti-tumor immunity and synergize with T cell checkpoint inhibitors in pre-clinical solid tumor models. Cancer Research. 81(13_Supplement). 63–63. 21 indexed citations

Gabitova, Linara, Rashid Gabbasov, Stefano Pierini, et al.. (2021). Abstract 1530: Anti-HER2 CAR monocytes demonstrate targeted anti-tumor activity and enable a single day cell manufacturing process. Cancer Research. 81(13_Supplement). 1530–1530. 9 indexed citations

Condamine, Thomas, Muriel Jager, Lucas Leclère, et al.. (2019). Molecular characterisation of a cellular conveyor belt in Clytia medusae. Developmental Biology. 456(2). 212–225. 11 indexed citations

Condamine, Thomas, Sherry Owens, Patricia Feldman, et al.. (2019). Abstract CT085: Pharmacodynamic correlates in a phase I study of INCMGA00012, a PD-1 antagonistic monoclonal antibody. Clinical Trials. CT085–CT085.

10.

Dominguez, George A., Thomas Condamine, Sridevi Mony, et al.. (2017). Abstract CT095: The selective targeting of myeloid-derived suppressor cells in cancer patients using an agonistic TRAIL-R2 antibody. Cancer Research. 77(13_Supplement). CT095–CT095. 1 indexed citations

11.

Dominguez, George A., Thomas Condamine, Sridevi Mony, et al.. (2016). Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody. Clinical Cancer Research. 23(12). 2942–2950. 152 indexed citations

12.

Kumar, Vinit, Pingyan Cheng, Thomas Condamine, et al.. (2016). CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation. Immunity. 44(2). 303–315. 313 indexed citations

13.

Kumar, Vinit, Pingyan Cheng, Thomas Condamine, et al.. (2016). CD45 phosphatase regulates the fate of myeloid cells in tumor microenvironment by inhibiting STAT3 activity. The Journal of Immunology. 196(1_Supplement). 211.4–211.4. 4 indexed citations

14.

Condamine, Thomas, Jérôme Mastio, & Dmitry I. Gabrilovich. (2015). Transcriptional regulation of myeloid-derived suppressor cells. Journal of Leukocyte Biology. 98(6). 913–922. 284 indexed citations

15.

Cao, Wei, Rupal Ramakrishnan, Filippo Veglia, et al.. (2014). Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer. The Journal of Immunology. 192(6). 2920–2931. 234 indexed citations

16.

Condamine, Thomas, Laëtitia Le Texier, Duncan Howie, et al.. (2010). Tmem176B and Tmem176A are associated with the immature state of dendritic cells. Journal of Leukocyte Biology. 88(3). 507–515. 67 indexed citations

17.

Condamine, Thomas & Dmitry I. Gabrilovich. (2010). Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends in Immunology. 32(1). 19–25. 691 indexed citations breakdown →

18.

Luduec, Jean-Benoît Le, Thomas Condamine, Cédric Louvet, et al.. (2008). An Immunomodulatory Role for Follistatin‐Like 1 in Heart Allograft Transplantation. American Journal of Transplantation. 8(11). 2297–2306. 49 indexed citations

19.

Thébault, Paméla, Thomas Condamine, M Heslan, et al.. (2007). Role of IFNγ in Allograft Tolerance Mediated by CD4+CD25+ Regulatory T Cells by Induction of IDO in Endothelial Cells. American Journal of Transplantation. 7(11). 2472–2482. 53 indexed citations

20.

Thébault, Paméla, Michèle Heslan, Thomas Condamine, et al.. (2007). Critical Role of IFNg in Allograft Tolerance Mediated by Foxp3+CD4+CD25+ Regulatory T Cells and the Production of Indoleamine 2, 3-dioxygenase by Graft Endothelial Cells. Clinical Immunology. 123. S130–S131. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact